Register your interest

To be able to deal with your enquiry effectively we will need to contact you via telephone and/or email. By enquiring below you consent to us contacting you via these methods.

Leading The Cannabis Revolution

One of the strongest EIS offers you'll see this year now available

Grow Biotech P.L.C allows you to access a unique market which is completely new to the UK. The market dynamics appear extremely favourable and the target return is attractive. Grow Biotech is focused on creating game-changing Intellectual Property in the fastest growing industry in the world, Medical Cannabis.

They are a cannabis biotech company with a uniquely global and nimble approach to cannabis science. This means constantly assessing the global-cannabis commercial and scientific landscape and only deploying their research capabilities to address the most exciting opportunities with the greatest scientific, medical and commercial potential.




Grow Biotech is uniquely positioned as one of the few cannabis IP asset development focused companies in the world and particularly one of only a handful with an international focus


Grow Biotech is building a diversified portfolio of cannabis-focused IP assets across brands, products, stains, and medical & process patents. Grow Biotech is also seeking to ensure that it has a truly global footprint and that it is not overly reliant on one market or one IP asset in particular

Register Interest


Global medical cannabis sales are estimated to be growing at a combined annual growth rate of around 50% from 2016 to 2020. Legal medical cannabis is currently the fastest growing market in the world and is undergoing rapid change as new countries legalise cannabis.


Target return of £50 per £1 invested (not guaranteed)


Up to 50% income tax and capital gains tax relief. Remember tax rules can change and benefits depend on circumstances.

Register Interest


There is increasing acceptance of the medicinal benefits of cannabis, and this has created strong momentum behind the legalisation drive. Israel is probably the world leader in terms of cannabis R&D, particularly focused on its medicinal benefits. The U.S. is one of many countries that is on a trend towards liberalisation of its cannabis laws. Other large countries are also gradually liberalising their laws, in addition to the 28 U.S. states and Canada, 12 EU countries have now legalised medical cannabis

Register your interest

To be able to deal with your enquiry effectively we will need to contact you via telephone and/or email. By enquiring below you consent to us contacting you via these methods.

Disclaimer: This investment offering has not been approved by a 'authorised person' under Section 21 of the Financial Services and Markets Act 2000. To view the content, you must be either: (a) High Net Worth Individual A high net worth individual is one who: Had, during the financial year immediately preceding the date of the certificate, an annual income of £100,000 or more. Held, throughout the same year, net assets of £250,000 or more excluding the residential home, a pension or the proceeds of life assurance contracts. or (b) Self-Certified Sophisticated Investor A sophisticated investor is someone who meets at least one of the following criteria: Has been a member of a network or syndicate of business angels for at least the six months preceding the date of the certificate. Has made more than one investment in an unlisted company in the two years preceding that date. Has worked, in the two years preceding that date, in a professional capacity in the private equity sector, or in the provision of finance for small and medium enterprises. Has been, in the two years preceding that date, a director of a company with an annual turnover of at least £1 million. If you do not meet these criteria, you must not take any further action. This website assumes you have a clear understanding of investments of this type and is provided to prospective investors to evaluate the investment being offered. Before you will be able to view the offering you must certify your investor status. Investments of this type carry significant risks and the capital you have invested will be at risk. This investment is not covered by the FSCS.